Epoetin alfa biosimilar (CJ Corp)

阿法依伯汀生物类似药 (CJ Corp)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameEpoetin alfa biosimilar (CJ Corp)
Drug Alias Name阿法依伯汀生物仿制药 (CJ Corp)Epoetin alfa follow-on biologic (CJ Corp)Epokine
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar
Mechanisms of ActionErythropoiesis stimulantsErythropoietin receptor agonists
TargetsErythropoietin receptor
Therapy Area/IndicationsIschemic StrokeAnemiaMoyamoya Disease +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesHK inno.N Corporation
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsAnemia
Inactive IndicationsIschemic StrokeMoyamoya DiseaseIschemic Attack, Transient

Other Information

ATC CodeB03XA01
Related LinksN/A